Expression of ER/PR Receptor, Her-2/neu, Ki67 and p53 in Endometrial Carcinoma: Clinicopathological Implication and Prognostic Value

被引：0
|
作者：
V. B. Shivkumar
Manisha A. Atram
Nitin M. Gangane
机构：
[1] Mahatma Gandhi Institute of Medical Sciences (MGIMS),Department of Pathology
[2] Mahatma Gandhi Institute of Medical Sciences,undefined
来源：
Indian Journal of Gynecologic Oncology | 2020年 / 18卷
关键词：
Endometrial cancer; ER/PR expression; Her-2/neu status; p53; Ki67;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [41] The prognostic value of the P53 protein and the Ki67 marker in breast cancer patients
    Golmohammadi, Rahim
    Pejhan, Akbar
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2012, 62 (09) : 871 - 875
  • [42] Prognostic role of ER, PR, HER-2/neu expression in the fallopian tubes' cancer
    Romaniuk, A.
    Gyryavenko, N.
    Lyndin, M.
    Romaniuk, O.
    Korobchanska, A.
    VIRCHOWS ARCHIV, 2017, 471 : S89 - S89
  • [43] P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression
    Coronado, PJ
    Vidart, JA
    Lopez-asenjo, JA
    Fasero, M
    Furio-bacete, V
    Magrina, J
    Escudero, M
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 98 (01): : 103 - 108
  • [44] Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma (vol 98, e13554, 2019)
    Peng, J-H
    Zhang, X.
    Song, J-L
    MEDICINE, 2022, 101 (04)
  • [45] Immunohistochemical Expression of Ki67 and p53 in Primary Breast Carcinoma and Combined Ki67-p53 Status Phenotypes in Hormone Receptor Positive Breast Carcinoma
    Baruah, Rishiraj
    Sumana, Bukanakere Sangappa
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (03)
  • [46] The expression of epidermal growth factor receptor, HER-2/neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma
    Swisher, EM
    Gown, AM
    Skelly, M
    Ek, M
    Tamimi, HK
    Cain, JM
    Greer, BE
    Muntz, HG
    Goff, BA
    GYNECOLOGIC ONCOLOGY, 1996, 60 (01) : 81 - 88
  • [47] ER、PR、Ki67、HER-2、P53在中青年女性乳腺癌中的表达及临床意义
    闫婕
    吴洁
    袁军华
    陈彬
    柳紫阳
    郭彦伟
    中外医疗, 2015, 34 (16) : 11 - 12
  • [48] ER、PR、Her-2、VEGF、p53和Ki67在乳腺癌中的表达及临床病理意义分析
    王娟
    黄炳臣
    吴雪铭
    苏群英
    林洁
    黄小英
    龙喜带
    右江医学, 2019, 47 (03) : 166 - 171
  • [49] Value of elevated Ki67 index (>10%) and p53 protein expression as prognostic factors in GIST
    Song, B.
    Jung, S.
    Kim, J.
    Oh, S.
    Park, J.
    Kim, S.
    Kim, W.
    Jeon, H.
    EJC SUPPLEMENTS, 2005, 3 (02): : 217 - 218
  • [50] MULTIVARIABLE ANALYSIS OF DNA-PLOIDY, P53, AND HER-2/NEU AS PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER
    LUKES, AS
    KOHLER, MF
    PIEPER, CF
    KERNS, BJ
    BENTLEY, R
    RODRIGUEZ, GC
    SOPER, JT
    CLARKEPEARSON, DL
    BAST, RC
    BERCHUCK, A
    CANCER, 1994, 73 (09) : 2380 - 2385
12345